The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis

被引:14
作者
Wang Ben [1 ,2 ,3 ,4 ]
Chen Lijie [6 ]
Huang Chongan [1 ,2 ,3 ,4 ]
Lin Jialiang [1 ,2 ,3 ,4 ]
Pan Xiangxiang [1 ,2 ,3 ,4 ]
Shao Zhenxuan [1 ,2 ,3 ,4 ]
Hu Sunli [1 ,2 ,3 ,4 ]
Zhang Xiaolei [1 ,2 ,3 ,4 ,5 ]
Wang Xiangyang [1 ,2 ,3 ,4 ]
机构
[1] Wenzhou Med Univ, Dept Orthopaed, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China
[3] Key Lab Orthopaed Zhejiang Prov, Wenzhou 325027, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Sch Med 2, Wenzhou 325027, Zhejiang, Peoples R China
[5] Chinese Orthopaed Regenerat Med Soc, Hangzhou, Zhejiang, Peoples R China
[6] Wenzhou Med Univ, Taizhou Hosp, Dept Surg Oncol, Taizhou 317000, Zhejiang, Peoples R China
来源
JOURNAL OF BONE ONCOLOGY | 2019年 / 17卷
关键词
Risk factors; Survival; Occurrence; Prognosis; Clinical guidelines; TRENDS; SURVIVAL; STATISTICS; HISTOLOGY; SITES; SEX;
D O I
10.1016/j.jbo.2019.100251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To analyse the homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients diagnosed with bone metastasis (BM) by using the Surveillance, Epidemiology, and End Results (SEER) database. Patients and methods: The medical records of lung cancer patients with or without bone metastasis were identified in the SEER database between 2010 and 2015. A multivariate logistic regression analysis was performed to identify risk factors, and a multivariate Cox regression was used to determine the prognostic effects of every variable on survival. Results: In total, 34,585 eligible patients from the SEER database were included in the analysis. Male gender and metastasis to the liver were factors that were both positively associated with a risk for the development and prognosis of bone metastasis in patients with lung cancer. Younger age, poor tumour differentiation grade, higher N stage (N3), adenocarcinoma and metastasis to the brain were all positively correlated with a risk of occurrence of BM, but these factors were not correlated with an unfavourable prognosis. Age, race, marital status, tumour size and pathologic type were independent risk factors for the prognosis of bone metastasis. Conclusion: The morbidity of bone metastasis in lung cancer patients is dismal, with a rate of 25.9%. The findings of this study estimate the homogeneous and heterogeneous risk factors for the occurrence and prognosis of bone metastasis in lung cancer patients, which may provide clinical guidelines for physicians.
引用
收藏
页数:8
相关论文
共 29 条
  • [1] [Anonymous], 2008, CANC INC 5 CONT, P1
  • [2] Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis
    Bae, Hyun-Mi
    Lee, Se-Hoon
    Kim, Tae Min
    Kim, Dong-Wan
    Yang, Seok-Chul
    Wu, Hong Gyun
    Kim, Young Whan
    Heo, Dae Seog
    [J]. LUNG CANCER, 2012, 77 (03) : 572 - 577
  • [3] Prognostic significance of sites of extrathoracic metastasis in patients with non-small cell lung cancer
    Bates, James E.
    Milano, Michael T.
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1903 - 1910
  • [4] Cook R. J., 2006, CLIN CANC RES 2, V12
  • [5] Epidemiology, management and cost of bone metastases from lung cancer
    Decroisette, C.
    Galerneau, L. -M.
    Hominal, S.
    Chouaid, C.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (04) : 309 - 315
  • [6] Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities
    DeSantis, Carol E.
    Siegel, Rebecca L.
    Sauer, Ann Goding
    Miller, Kimberly D.
    Fedewa, Stacey A.
    Alcaraz, Kassandra I.
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (04) : 290 - 308
  • [7] International lung cancer trends by histologic type:: male:female differences diminishing and adenocarcinoma rates rising
    Devesa, SS
    Bray, F
    Vizcaino, AP
    Parkin, DM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) : 294 - 299
  • [8] Lung cancer: current therapies and new targeted treatments
    Hirsch, Fred R.
    Scagliotti, Giorgio V.
    Mulshine, James L.
    Kwon, Regina
    Curran, Walter J.
    Wu, Yi-Long
    Paz-Ares, Luis
    [J]. LANCET, 2017, 389 (10066) : 299 - 311
  • [9] Annual Report to the Nation on the Status of Cancer, 19752009, Featuring the Burden and Trends in Human Papillomavirus (HPV)Associated Cancers and HPV Vaccination Coverage Levels
    Jemal, Ahmedin
    Simard, Edgar P.
    Dorell, Christina
    Noone, Anne-Michelle
    Markowitz, Lauri E.
    Kohler, Betsy
    Eheman, Christie
    Saraiya, Mona
    Bandi, Priti
    Saslow, Debbie
    Cronin, Kathleen A.
    Watson, Meg
    Schiffman, Mark
    Henley, S. Jane
    Schymura, Maria J.
    Anderson, Robert N.
    Yankey, David
    Edwards, Brenda K.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (03): : 175 - 201
  • [10] Sex differences in lung cancer survival: long-term trends using population-based cancer registry data in Osaka, Japan
    Kinoshita, Fukuaki Lee
    Ito, Yuri
    Morishima, Toshitaka
    Miyashiro, Isao
    Nakayama, Tomio
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (09) : 863 - 869